Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5551412 | 0.81 | EPHX1 (0.38) | EPHX1NAAASHBGCYP1A2 | |
| SCHEMBL21248072 | 0.80 | EPHX1 (0.36) | EPHX1NAAASHBGADH1CADH1A | |
| SCHEMBL27104105 | 0.80 | EPHX1 (0.36) | EPHX1NAAASHBGADH1CADH1A | |
| SCHEMBL5031013 | 0.78 | NAAA (0.41) | EPHX1NAAACYP1A2 | |
| Methylamine SCHEMBL2251740 | 0.78 | EPHX1 (0.36) | EPHX1NAAACYP1A2CA1CA2 | |
| SCHEMBL29050162 | 0.77 | EPHX1 (0.33) | EPHX1NAAA | |
| SCHEMBL301545 | 0.77 | EPHX1 (0.38) | EPHX1NAAA | |
| SCHEMBL11414892 | 0.76 | EPHX1 (0.34) | EPHX1NAAASHBG | |
| SCHEMBL5031089 | 0.76 | NAAA (0.43) | EPHX1NAAACYP1A2 | |
| SCHEMBL5029803 | 0.75 | CYP19A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1999167-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | Novolen Technology Holdings, C.V. (NL) | 2008-12-10 | — | — | EP | disclosed |
| WO-2007106348-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213204-A1 | Ziegler-Natta catalyst with in situ-generated donor | NOVOLEN TECHNOLOGY HOLDINGS C.V. | 2007-09-13 | — | — | US | disclosed |